Egnite - Crunchbase Company Profile & Funding

Q: Where is Egnite's headquarters?

Egnite is located in Aliso Viejo, California, United States.

Overview

Egnite

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+4 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Egnite

CB Rank

156195

Egnite delivers actionable insights through intuitive digital-health platforms, proprietary artificial-intelligence-powered analytics.

Founded

obfuscation

Private

Aliso Viejo, California, United States

101-250

egnitehealth.com/

Analytics

Artificial Intelligence (AI)

Health Care

Hospital

Key People

Joel Portice: President and CEO
Past Role: Intermedix, Chief Executive Officer

Details

Legal Name

egnite, Inc.

Operating Status

Active

Company Type

For Profit

Predictions & Insights

Growth Insight

See this Growth Insight

Egnite is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

CardioCare Platform

An AI-driven digital health platform that identifies and manages at-risk cardiovascular patients by analyzing echocardiogram data to support clinical decision-making and care prioritization.

Therapy Accelerator & Research Ecosystem

A real-world data ecosystem that supports life sciences organizations in cardiovascular research and clinical trial enrollment by leveraging extensive cardiovascular patient data.